🇺🇸 FDA
Patent

US 6326466

Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner

expired A61KA61K38/00

Quick answer

US patent 6326466 (Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K38/00